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Abstract
Background: Prior research from India demonstrates a need for family planning counseling that engages both
women and men, offers complete family planning method mix, and focuses on gender equity and reduces marital
sexual violence (MSV) to promote modern contraceptive use. Effectiveness of the three-session (two male-only sessions
and one couple session) Counseling Husbands to Achieve Reproductive Health and Marital Equity (CHARM)
intervention, which used male health providers to engage and counsel husbands on gender equity and family
planning (GE + FP), was demonstrated by increased pill and condom use and a reduction in MSV. However, the
intervention had limited reach to women and was therefore unable to expand access to highly effective long acting
reversible contraceptives such as the intrauterine device (IUD). We developed a second iteration of the intervention,
CHARM2, which retains the three sessions from the original CHARM but adds female provider- delivered counseling to
women and offers a broader array of contraceptives including IUDs. This protocol describes the evaluation of CHARM2
in rural Maharashtra.
Methods: A two-arm cluster randomized controlled trial will evaluate CHARM2, a gender synchronized GE + FP
intervention. Eligible married couples (n = 1200) will be enrolled across 20 clusters in rural Maharashtra, India.
Health providers will be gender-matched to deliver two GE + FP sessions to the married couples in parallel,
and then a final session will be delivered to the couple together. We will conduct surveys on demographics
as well as GE and FP indicators at baseline, 9-month, and 18-month follow-ups with both men and women,
and pregnancy tests at each time point from women. In-depth interviews will be conducted with a subsample of
couples (n = 50) and providers (n = 20). We will conduct several implementation and monitoring activities for purposes
of assuring fidelity to intervention design and quality of implementation, including recruitment and tracking
logs, provider evaluation forms, session observation forms, and participant satisfaction surveys.
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Discussion: We will complete the recruitment of participants and collection of baseline data by July 2019.
Findings from this work will offer important insight for the expansion of the national family planning program and
improving quality of care for India and family planning interventions globally.
Trial registration: ClinicalTrial.gov, NCT03514914.
Keywords: Family planning, Cluster randomized controlled trial, Intervention, Contraceptive use, Gender equity, Marital
sexual violence
Plain English summary
The protocol aims to describe the implementation and
evaluation of a gender synchronized family planning
intervention CHARM2 [Counseling Husbands and wives
to Achieve Reproductive health and Marital equity 2] to
wives ages 18–29 years and their husbands through local
health providers in Maharashtra, India. A gender
matched healthcare provider will conduct five sessions
with the couple including, two sessions with husbands,
two sessions with wives, and one with the couple to-
gether. The intervention aims to improve contraceptive
use as well as reduce unintended pregnancy and marital
sexual violence. The participants will also be offered ex-
panded contraceptive method choices. CHARM2 not
only engages husbands, but also focuses on women’s re-
productive autonomy and improved availability of
LARCs. The intervention also engages public as well as
private health care providers to support infrastructure
for implementation. The study will be evaluated using
quantitative surveys at baseline, 9 months and 18 months
follow-ups, and qualitative in-depth interviews with cou-
ples and health care providers as well. The findings from
this study will inform the national public family planning
program in India and offer insights for interventions
globally.
Background
Globally, 41% of all pregnancies are unintended [1, 2],
increasing risk for poor maternal and neonatal health
outcomes [3–5]. Most unintended pregnancies occur
among women who use no contraception; one in three
is due to contraceptive failure [6]. Poor, rural and young
women are at greatest risk for both contraceptive non-
use and failure, with the latter being a consequence of
reliance on traditional and short-acting contraceptives
(e.g., pill, condom) rather than more effective long-
acting reversible contraceptives (LARC) (e.g., IUD) [5,
7]. These young women are also more vulnerable to
marital sexual violence (MSV), compromising their re-
productive control and contraceptive use [8, 9]. Family
planning interventions that engage men as well as
women, address gender inequities in marital relation-
ships, support women’s reproductive control and safety
from MSV, and provide the full range of available effect-
ive contraceptive options including LARC are needed.
Rural India, with some of the lowest rates of contracep-
tion and highest rates of marital violence globally [10–
12], is an important context in which to implement and
test such interventions.
The Counseling Husbands and wives to Achieve Re-
productive health and Marital equity 2 (CHARM2)
intervention is based on findings from our evaluation of
the original CHARM study, an innovative, brief (2 men’s
sessions and 1 couples’ session), gender equity and fam-
ily planning (GE + FP) intervention delivered by male
health providers in rural Maharashtra, India. A two-arm
cluster randomized controlled trial (RCT) compared the
CHARM intervention to the standard of care (SOC)
public health services (community outreach to women
and linkage to family planning (FP) clinics) to determine
its impact on reversible contraceptive use and unin-
tended pregnancy [13]. CHARM demonstrated increased
modern contraceptive use, but no reduction in unin-
tended pregnancy [14]. This male-delivered model had
strong participation from men (91%), but less from cou-
ples (51%), largely due to preferences for gender-
matched providers [14]. Poor reach to women and
provision of only moderately effective contraceptives
(pill, condom) [5], likely compromised unintended preg-
nancy outcomes. CHARM was associated with a reduced
risk for MSV, a concern for almost 1/3 of women in the
study sample [14] and a significant risk factor for con-
dom non-use and oral contraceptive failure [15, 16].
These findings indicated that original CHARM sessions
for men would benefit from sessions for women, deliv-
ered by a female auxiliary nurse midwife (ANM) and in-
clusive of a broader array of contraceptive options,
including LARC. The recent expansion of FP services in
India to prioritize nurse-delivered IUDs [17] and more
recently, injectables [18], is aligned with study goals and
will be supported by implementation.
The CHARM male engagement focused FP interven-
tion required adaptations to better support women’s en-
gagement and reproductive autonomy. These include
improved availability of LARCs, and female-focused gen-
der equity and FP counselling sessions delivered by
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female providers, paired with the male provider-delivered
men’s sessions. We have incorporated these adaptations
into the CHARM2 intervention, which we are evaluating
via a two-arm cluster RCT. The CHARM2 intervention
further engages public-private partnership to support in-
frastructure for implementation, if successful. This paper
describes our study protocols for the quantitative, qualita-
tive, and implementation-science based evaluation of
CHARM2 in rural Maharashtra, India. Quantitative evalu-
ation will assess the impact of CHARM2 on contraceptive
use, unintended pregnancy, and MSV. We will also de-
scribe elements of our implementation framework and
monitoring to ensure high-quality delivery of the interven-
tion and for purposes of its replication, as well as a quali-
tative evaluation of the intervention in terms of
participant and provider perceptions of the mechanisms
that may explain behavior change.
Methods
The study has two phases. Phase 1 was preparatory and
entailed mapping the project area and preparing com-
munities for the planned research. Phase 2 entails imple-
mentation and evaluation of CHARM2, using a two-arm
cluster RCT in the geographic clusters mapped in Phase
1, via surveys and pregnancy testing at baseline and 9 &
18-month follow-up with n = 1200 couples, coupled with
in-depth interviews (IDIs) with providers, couples, and
stakeholders.
Setting
This study is being conducted in Pune District, Maharash-
tra, which has a rural population of 3.7 million residents
across 2000 villages [19, 20]. In rural Pune, female
illiteracy is 27%, and the child sex ratio is 833 girls per
1000 boys (indicative of son preference/missing girls) [19,
20]. Only 25% of non-sterilized women of childbearing
age use modern contraception [21]. Within Pune District,
we focus on rural Junnar Taluka (taluka: geographic sub-
district area), which is comprised of 183 villages (pop. 399,
000). As in most of India, Junnar’s public health structure
is hierarchical, with two community health centers
(CHCs) offering inpatient and surgical facilities and 12
primary health centers (PHCs; 6 PHCs under each CHC)
with maternal delivery beds, infant incubators, and FP ser-
vices. Under each PHC, there are 3–10 sub-centers (SCs;
total 74 in Junnar), in which ANMs provide maternal,
newborn, and child health (MNCH) and family planning
services. Each SC serves a population of about 5000 in
non-tribal areas and 3000 in hilly areas. In consultation
with the department of health and family welfare of
Maharashtra state and Pune district health offices, 5 PHCs
in Junnar taluka were selected for the CHARM2 study.
These five PHCs includes 20 subcenters, providing health
services to approximately 150,000 individuals. There are
nearly 30,000 households spread across 41 villages and
hamlets (habitant areas attached to administrative demar-
cation of a revenue village).
To understand the study area, our field research team
conducted a detailed community mapping exercise under
the supervision of the leadership team in India. We used
maps generated by PHCs to identify SC boundaries and
major villages within SCs. We collected the following in-
formation at the community level: key persons (ANM,
accredited social health activist (ASHA), integrated child
development services (ICDS) worker, and heads of village
panchayats: a village council), availability of infrastructure
(SC, ICDS Anganwadi center and village panchayat office),
transportation facilities (road, rail network), topographic
features (hilly area), hamlets and villages, distance to the
nearest PHC, and locations of private health providers. In
addition, we reviewed seasonal climatic conditions such as
rainfall and temperatures to understand the feasibility of
work by month. Further, population characteristics, work
force, schooling, employment opportunities, and in and
out migration were collected. A physical map of the study
area was developed to depict the key information col-
lected. These data help clarify cluster geographies for
randomization.
CHARM2 intervention
Theoretical framework
As with the original CHARM intervention, the
CHARM2 intervention is based on Bandura’s Social
Cognitive Theory (SCT) [22] and Theory of Gender and
Power (TGP) [23]. SCT has been identified as one of the
most commonly used behavioral theories in FP interven-
tions [24]. SCT posits that behavior change, in this case
contraceptive use, is more likely if an individual has
positive outcome expectations for engaging in the behav-
ior (e.g., believes that birth spacing will produce health-
ier children), feels capable of engaging in and controlling
the behavior (i.e., self-efficacy to use contraception), and
has an environment supportive of the behavior (e.g., ac-
cess to FP services). Hence, SCT would support the use
of FP education and skills building together with im-
proved contraceptive access. TGP is a social-structural
theory that posits that the gender-based power dynamics
inherent to many heterosexual couples are due to societ-
ally reinforced social norms [23]. Such norms can facili-
tate male control over sexual and reproductive decision-
making, including contraceptive use. Some men may
even use violence, including MSV, to control their fe-
male partners. Hence, counseling that can affect norma-
tive beliefs around gender equitable family planning,
particularly if the counseling is delivered by a respected
and gender-matched role model (local health providers
and counselors; ideally inclusive of a public health nurse
for delivery of women’s sessions), can be useful in
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improving contraceptive use in the context of safer and
healthier relationships.
Development of CHARM2
We developed the CHARM2 curriculum using the ori-
ginal CHARM curriculum [14], updating and adding in-
formation based on the Government of India’s family
planning resources including standard public health
counseling guides and details on available contraceptives
[25–28]. CHARM2 differs from the original CHARM
intervention by adding two sessions just for wives, deliv-
ered by a female provider or counselor trained in family
planning, and including a broader family planning
method mix including IUD. For both the men’s and
women’s sessions, we again used Government of India
resources, but also added an adapted version of Popula-
tion Council’s Balanced Counseling Strategy (BCS) tool,
to support patient-centered contraceptive choice
through information exchange that allows for selection
of a method that meets the reproductive needs of the
client [29]. Additionally, the women’s session included
counseling on reproductive coercion, to guide women to
consider how they may safely engage in contraceptive
use if they choose and a partner is opposed to it and/or
abusive [30].
Once there was clarity on the model and approach, a
team led by a family planning clinical researcher devel-
oped a detailed curriculum, created a flip chart for use
as a tool for CHARM2 providers to use with participants
in the field, and generated a set of index cards detailing
use, duration of action, efficacy, side effects and contra-
indications for each method. The team also developed a
training manual on how to use the curriculum as a refer-
ence guide for providers. The curriculum included ex-
tensive details on contraceptives to ensure safe and up-
to-date provision by providers. The curriculum and flip-
chart detailed Women’s Sessions 1 and 2, Men’s Sessions
1 and 2, and the Couples’ Session. A graphic artist then
worked with the team to update or create additional
graphics for all materials. Once the materials were devel-
oped, local family planning providers reviewed and pro-
vided feedback, which we revised and finalized in order
to ensure user-friendly materials. We used these mate-
rials for the training of CHARM2 providers, as well as
for program implementation.
Through provider training and the curriculum, em-
phasis on the right to respectful and non-coercive family
planning counseling was included as part of the
CHARM2 approach [31]. The curriculum was designed
to support providers to exchange information with par-
ticipants, to allow them to choose a method that suits
their reproductive goals. Additionally, providers deliver-
ing the sessions are local trained health providers and
counselors, including for the women, qualified auxiliary
nurse midwives (ANMs) within the public health system.
The ANM’s training and position facilitates access to
publicly available contraceptives and allows her to pro-
vide IUDs to women who opt for them free of charge,
though all CHARM2 providers are given access to pub-
licly funded contraceptives as part of their participation
in this study, as we have connected the study to the local
district health centers and primary health centers. While
injectables were not available through the Maharashtrian
public health system, if they become available through
the course of the trial, ANMs would also be in a position
to provide that option. As noted previously, private fe-
male providers can deliver the intervention in the ab-
sence of any available ANM, which can be the case for
subcenters with vacancies.
Overview of the CHARM2 intervention
As noted above, the CHARM2 intervention involves five
gender, culture and contextually-tailored FP + GE coun-
seling sessions. (Table 1) Gender-synchronized sessions
are delivered individually to husbands by a trained male
health provider (2 sessions), and in parallel, delivered in-
dividually to wives by a trained female provider (2 ses-
sions). Following the delivery of the individual sessions,
there is a couple counseling session (1 session), delivered
by either the male or female provider who delivered the
individual sessions, whichever is available. We anticipate
that these will often be delivered by female providers,
who may be more available to this project than male
providers. Session content and length are noted in Table
1 below. Sessions are provided in a confidential setting
including at the community center or within the clinical
setting. For each couple, all three sessions are to be de-
livered across 4 months with 1 month between the ses-
sions. The men’s first session must be delivered before
or at the same time as the female session. We provide
all sessions and contraceptives at no cost to participants.
Wives, in-laws and other decision-makers may be in-
cluded in men’s session two if requested by the male
participant. Given concerns about IUD side effects [32]
such as cramping [33], as well as findings of high revers-
ible contraceptive failure in India [11], the female pro-
vider will provide follow-up on contraceptives to
support contraceptive continuation and satisfaction [34].
CHARM2 provider selection and training
Provider selection
CHARM2 engages both female (ANM) and male health
providers. All ANMs operating in an intervention SC at
the time of intervention delivery were selected for inclu-
sion in this study. Per government policy, all ANMs are
trained in family planning counseling and services in-
cluding IUD insertion. To identify ANMs, we collected a
list of ANMs working across all SCs within participating
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PHCs. We approached PHCs in our study site and
gained approval for collaboration on this project, in
preparation for the study. We compiled contact details
for the ANMs and their SCs and approached ANMs
from the intervention clusters (10 SCs) to confirm will-
ingness and ability to conduct counseling sessions with
female intervention participants for individual sessions
and with husband and wife together for the couple ses-
sion. In that process, we learned that ANM vacancies at
SCs are not uncommon, and some ANMs were not yet
trained in IUD insertion. In cases of vacancies, ANMs at
nearby SCs cover the SC with a vacancy. This finding
complicated the original design, and we addressed this
concern through the following means: We provided all
ANMs in intervention SCs, regardless of whether they
received IUD insertion training, the CHARM2 train-
ing, but training and data collection were prioritized
in SCs with no vacancies, to allow time for the va-
cancy to be filled. Local female providers not at SCs
were also included as back-up in cases where ANMs
were unavailable.
To select the male providers, we identified local male
allopathic and non-allopathic (AYUSH, traditional medi-
cine) providers working in our intervention SCs via lists
maintained by PHCs and through the mapping proced-
ure we undertook in preparation for the study. These
were largely private providers. Study staff approached all
providers with allopathic or AYUSH credentials to assess
their willingness to participate in the study. An add-
itional criterion for selection was no plan to move from
Table 1 CHARM2 Intervention Program Outline for Rural Young Couples
SESSION 1
For Men (20–40 min); Delivered by Male Health Provider
• Assess client’s FP knowledge and fertility goals; provide an overview of FP types/effectiveness/availability, encouraging discourse around methods
that suit his needs.
• Provide info on maternal and child health benefits of FP, as well as delayed first childbirth
• Assess sex risk of man: extramarital sex; provide basic HIV/STI prevention information
• Briefly assess if a man has discussed FP with his wife; assess & encourage joint FP decision-making
• Highlight the importance of male involvement in FP
• GE issues- son preference
• Review again client’s FP goals; encourage consideration of contraception.
For Women (20–40 min); Delivered by ANM
• Assess client’s FP knowledge and fertility goals; provide an overview of FP types/effectiveness/availability, encouraging discourse around methods
that suit her needs.
• Provide info on maternal and child health benefits of FP, as well as delayed first childbirth
• Assess sex risk of woman: extramarital sex; provide basic HIV/STI prevention information
• Briefly assess if a woman has discussed FP with her husband; assess & encourage joint FP decision-making
• Highlight the importance of male involvement in FP
• GE issues- son preference, sexual/reproductive control/coercion
• Review again client’s FP goals; encourage consideration of contraception.
SESSION 2
For Men (20 min); Delivered by Male Health Provider
• Assess client’s FP goals; review FP types/effectiveness to support these goals, encouraging discourse around methods that suit his needs.
• Review previously identified barriers to FP uptake- such as the desire for sons or pressure from in-laws
• Assess if a man has discussed FP with his wife; practice how to communicate about FP
• Assess marital violence and sexual communication; reinforce non-use of violence and respectful communication; encourage joint FP decision
making with wife
• Highlight the importance of male involvement in FP, affection in a sexual relationship
• GE issues- son preference, sexual/reproductive control/coercion
• Review again client’s FP goals; encourage consideration of contraception.
For Women (20 min); Delivered by ANM
• Assess client’s FP goals; review FP types/effectiveness to support these goals, encouraging discourse around methods that suit her needs.
• Review previously identified barriers to FP uptake- the desire for sons or pressure from in-laws
• Assess if the woman has discussed FP her husband; practice how to communicate about FP with husband
• Discuss marital violence and sexual communication; reinforce non-use of violence and respectful communication; encourage joint FP decision
making with husband
• Highlight the importance of male involvement in FP
• GE issues- son preference, sexual/reproductive control/coercion
• Review again client’s FP goals; encourage consideration of contraception
SESSION 3- For Couples Together (20–40 min); Delivered by ANM or Male Provider
• Provide an overview of health benefits and types/effectiveness of FP, including LARC methods; Assess FP goals; Counsel on fertility and FP joint
decision-making; Validate Contraceptive Choicesa
• GE issues- son preference
• Discuss marital communication, sexual communication- FP and MSV
• Provide support to obtain methods; follow-up with women regarding satisfaction with contraception every 2 months until satisfaction and safety
are confirmed
aNOTE: This piece of the CHARM2 ANM session is SOC for ANM FP services
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the local area in the next 2 years, to ensure continuity of
care. We ultimately decided to include both male and fe-
male allopathic and AYUSH providers in our selection
process, as female providers can serve as CHARM2 fe-
male participants in cases where ANMs are not available
due to vacancies, as noted above. As back up in cases of
shortages of male providers, we also included and
trained male social workers and male multi-purpose
health workers (MPWs) from the public health system
to deliver the CHARM2 intervention.
Provider training
We trained all willing and eligible providers to partici-
pate in the CHARM2 intervention. In our initial 2-day
training, we trained a total of 39 providers, including 8
male and 20 female private providers, and 12 male and 9
female providers working in the public health system.
We provided an initial training from behavioral and
public health scientists. The training included an intro-
duction to the objectives and design of the CHARM2
intervention program, and why we designed it, as well as
background on the original CHARM intervention. We
then provided a review of contraceptives and family
planning counseling approaches, and education on the
value of healthy pregnancy spacing, high-quality inter-
personal communication between husband and wife and
between patient and provider, and legality and safety of
abortion. We then held facilitated discussions on social
and gender norm-related barriers to family planning use,
including underlying values of gender equity and repro-
ductive choice, shared family planning decision making
for couples, fertility norms and expectations, son prefer-
ence, decision-making control, respectful marital com-
munication, masculinity norms, in-law involvement,
spousal violence, and reproductive coercion from hus-
bands and in-laws. Post-test evaluations of this training
indicate good clarity across providers on issues of family
planning and gender equity.
We expect to provide more training sessions given the
turnover of staff at SCs and PHCs as well as some antici-
pated loss of other private providers. We also anticipate
refresher trainings for trained providers immediately
prior to roll out of an intervention in their SC. The
booster trainings will focus on family planning options,
non-coercive and high-quality delivery of care, and social
and gender norms constraining family planning prac-
tices. Additionally, as ANMs may be serving more than
one SC, there may be a risk for contamination if she is
in both an intervention SC and a control SC; in these
cases, we will provide training on ways to avoid contam-
ination. (See Randomization section below.)
We will track training of all providers and monitor
intervention delivery to support improved quality of im-
plementation among providers where needed. We will
also maintain data on providers in terms of their sex,
educational qualifications, years of experience in prac-
tice, years of experience delivering FP counseling, patient
load, and hours/days of availability to participate in
CHARM2. These data will allow us to assess potential
biases in the retention of providers in the study.
Outcome evaluation of CHARM2
Study design
A two-arm cluster RCT will compare the intervention
arm (FP + GE delivered over 5 sessions with men,
women, and couples) with the control arm receiving
SOC FP services from the public health system. Surveys
are administered to all participants (intervention and
control arms), and pregnancy tests from all female par-
ticipants, at baseline, 9-month follow-up and 18-month
follow-up We will evaluate the impact of CHARM2,
relative to the control condition, on reversible contra-
ceptive use, pregnancy, and MSV over time. (See Fig. 1.)
Randomization
To maintain the CHARM2 intervention within the pub-
lic health system and utilize the system’s trained ANMs
to deliver the intervention sessions to women, we ran-
domized at the SC level, i.e., the public health system’s
most local facility, at which ANMs are located. Hence,
SCs operated as our cluster for this RCT. Given that SCs
are under PHCs, as noted above, we randomized within
PHCs, to ensure that administrative cultures of given
PHCs did not create bias in our design. We then ran-
domized our 20 SCs (i.e., our clusters), stratified within
our three PHCs, into intervention and control condi-
tions in the month prior to enrollment initiation. Re-
search staff are not blinded to the treatment condition
assignment to clusters.
Recruitment
Within each SC, we randomly selected households with
couples meeting inclusion criteria into this study. Our
field research staff, in male-female pairs, conduct house-
hold screening to identify eligible couples, and then se-
lect n = 60 couples on the list, per SC, for study
inclusion. In a small cluster if the total number of cou-
ples is less than or equal to 60, all couples are recruited.
In a more populous cluster if the couple size is more
than 60, we randomly select 60 couples from the list. In
geographically large clusters, we limit household screen-
ings to most populous areas to reduce burden on the
staff for recruitment. If an eligible household has two or
more couples meeting eligibility criteria, a Kish Grid is
used to determine the couple to be selected. All partici-
pants provide informed consent before screening and
are provided with information about local available pub-
licly supported family planning services.
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Eligible study participants include couples in which
women report to be between 18-29 years of age and the
couple is not sterilized, has resided in the village to-
gether for 3 months, is planning to stay in the current
place of residence for at least 2 years, is fluent is Maharti
and are both willing to participate in the study. Ineligible
participants include any couple that identifies as having
a spouse with cognitive impairment and/or as sterile/in-
fertile. Pregnant women are eligible to participate, as
study outcomes, including contraceptive use and unin-
tended pregnancy, are still possible and meaningful at
follow-up for those pregnant at baseline. For those that
decline study participation, the reason for refusal is
noted, and demographics collected for consideration of
participation bias.
Study procedures
Once we select couples for study inclusion from the
screened household listing of eligible couples per cluster,
research teams visit the households of these couples to
invite them into the study. Staff make at least three at-
tempts to enroll selected couples into the study. Eligible
couples complete the written informed consent process
immediately prior to survey participation. Research staff
conduct surveys using electronic tablets with couples,
separately and with gender-matched interviewers, in a
private or confidential setting. We use electronic tablets
rather than paper surveys to reduce the likelihood of
interviewer error and loss of data, and to eliminate sec-
ondary data entry efforts for quality control.
Following completion of the women’s survey, female
participants take a urine pregnancy test under the direc-
tion of the female research staff member in a private lo-
cation, away from the husband. The husband is not
informed of the pregnancy test or results. The pregnancy
test is not carried out if the woman is < 40 days postpar-
tum, 30 days post miscarriage, or currently pregnant in
the 2nd/3rd trimester. A woman may refuse to test for
any reason. Test results are available within three mi-
nutes of testing and staff add test results into the survey.
The research investigators wait a minimum of two full
minutes before looking at the pregnancy test result, and
then collect and dispose of it. If a woman asks for fur-
ther information or confirmation on whether she is
pregnant, the enumerator must direct her to contact the
SC/PHC. Enumerators record all reasons for pregnancy
test refusal. The interviewer then notifies the woman of
her test results and offers information about her local
SC, PHC and contact details of an ASHA to seek ante-
natal and family planning services as appropriate. Staff
keep the pregnancy tests and dispose of them at the end
of the day, to ensure proper and confidential disposal.
The female research staff informs all women, regard-
less of treatment group, of available family planning ser-
vices in the area. If domestic violence is identified, the
research staff also provides contact information for
Mahila Hakka Suraksha Samiti, Nashik, a Pune-based
domestic violence program that can provide safety and
protection for women. If a woman indicates immediate
life-threatening abuse, she is withdrawn from the study
and provided the appropriate referrals. Staff do not in-
form husbands about these referrals or the violence
questions. All participants are informed that free contra-
ceptives are available through the public health system,
domestic violence is illegal, and abortion is legal.
After the baseline survey, research staff inform inter-
vention couples regarding locations and contacts for de-
livery of the CHARM2 intervention sessions and
support and link them to their CHARM2 provider, with
assistance from ASHA operating at the village level. Par-
ticipants are reminded that data will be collected from
them again in 9 & 18months. Research team members
further assist couples to make their appointments with
the providers for intervention sessions. Following ap-
pointment confirmation, research staff contact partici-
pants 3–4 days prior to the appointment and the day
before, to further support the initial visit. Provider visits
can occur at a location of the participant and provider’s
choosing, such as the clinic or in the participants’ com-
munity, as long as privacy for counseling is possible. Re-
search staff provide control group participants with SOC
information regarding clinic locations and FP services
available at the SC and PHC. We also inform ASHAs of
these participants so they may support participant link-
age to the public health system.
Research staff, ideally the same interviewers who col-
lect data at baseline, will conduct follow-up assessments
at 9- & 18-months post-baseline with both treatment
Intervention (CHARM2)
(n = 600 couples)
9 &18-month follow-up survey and pregnancy 
testing outcomes: contraceptive use, MSV, 
and unintended pregnancy
Randomize 
village 
clusters 
Baseline Survey 
with Couple
(n=1200), 
Control Condition
(n = 600 couples)
Pregnancy Test
Fig. 1 Outcome Evaluation Study Design
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and SOC groups using the same procedures as in base-
line data collection. Study participants do not receive in-
centives. Please see Table 2 for the schedule of
enrollment, intervention, and assessments.
Outcome measures
Baseline and follow-up surveys were created by the US
and India-based CHARM2 team, using validated mea-
sures from India’s Demographic Health Survey (DHS-
NFHS-4) and original CHARM study survey wherever
possible. For additional measures, we sought those pre-
viously published in peer-reviewed papers, demonstrat-
ing good psychometric properties, and previously used
in India. The survey includes items and scales on demo-
graphics, marital history, control over resources, preg-
nancy and fertility histories and preferences, family
planning history and counseling experiences, gender role
norms, marital violence and relationship dynamics, sex-
ual history, and mental health. (See Table 3 for more de-
tails on constructs measured. Survey and measurement
citations are available upon request).
Subsequent to development of the survey, multiple
English/Marathi bilingual survey researchers trained and
experienced in working on sexual health and family
planning studies reviewed the survey for clarity, accur-
acy, and ease of use. Trained field investigators then
pilot tested the survey tool using paper surveys with 20
eligible couples from a single village outside of the study
area. Pilot testing allowed for the collection of feedback
regarding question administration, wording, response
options, and question order. Based on feedback from
these efforts, our team finalized the survey and pro-
grammed it into the electronic survey tablet system.
Field researchers collected initial surveys (during the
first 22 days of implementation) on paper and then
transferred these into the tablet system to ensure its
strong functioning. Subsequently, we eliminated paper
surveys, and we plan to collect all remaining survey data
on the programed electronic tablets, which use Comm-
Care software.
Field researcher training and monitoring
All field research staff were Masters level professionals
with degrees in social work or counseling and were
trained on and experienced with rural field research and
survey data collection in the fields of health and social
services. Scientists within our investigator team select
staff via a competitive hiring process, and then train
them over the course of 2 weeks on family planning and
CHARM2 research protocols. We also trained the field
research team over 1 week on survey implementation of
the CHARM2 survey, inclusive of use of the CommCare
Table 2 Schedule of enrollment, intervention, and assessments
e
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tablet system with a training manual developed for this
study. An ICMR-NIRRH affiliated gynecologist provides
training to the field staff on how to administer and read
a pregnancy test. The scientist supervisor on site, who
has more than 30 years of experience working on rural
field research related to family planning, meets with the
team weekly to review work, identify issues and address
them, and provide supplemental training or course cor-
rection as needed. A field manager also works to oversee
all field research at sites, via periodic observations, and
reviews output daily to ensure quality control of data.
This includes monitoring of daily enrollment data, track-
ing follow-up assessments and confirming a plan of ac-
tion for follow-up, and monitoring the participation and
follow-up rate daily to maintain high retention rates.
This system enables our team to generate reports to
track follow-up data on a timely basis, to identify miss-
ing or late data, and to support research staff to address
any issues quickly.
Data management and monitoring
Field researchers upload all electronic survey data daily
into the CommCare system, which allows for access to
data for all investigators across institutions simultan-
eously, but is password protected to ensure privacy of
data. All data are de-identified; our team labels elec-
tronic survey data with a unique identifier specific to an
individual participant to allow for linkage of baseline
and follow-up data and linking of couple data to each
other, for purposes of analysis. Field research staff
maintain tracking forms on paper for all participants,
with identifiable information on name and location and
basic demographics (e.g., age, sex), as well as additional
contacts to facilitate follow-up and tracking. We store all
paper-based identifying information in a locked cabinet
at the field investigator site, and we maintain electronic
identifiable data records linking names/locations with
the unique identifier, separate from survey data, on a
password-protected server that is only accessible by field
staff and supervisors, to ensure quality tracking and link-
age of data. We also maintain an excel monitoring
spreadsheet summarizing information on schedule of
study assessments and intervention delivery to ensure
timely follow-up; this monitoring sheet is developed and
managed by the field supervisor and used to update
study investigators on data collection via twice monthly
to weekly calls with the full investigator team, across
India and the US. We will also use the data on interven-
tion participation recorded in the monitoring spread-
sheet for our dose analyses. To ensure high-quality
survey data, our data analyst also conducts data
consistency checks and provides a monthly report on
these data for review by senior investigators on the
study.
Sample size determination
At baseline n = 1200 sample will be collected, where
80% of couples are expected to be retained (i.e., n = 960)
by 18 months follow up. This sample size was deter-
mined based on expected treatment effects detectable
Table 3 Content of CHARM2 Survey
Topics and Constructs Description
Socio-economic and demographic
characteristics
Age, residency, education, religion, caste, household members, employment, income, economic assess
ownership, food insecurity, debt, proximity to parents, tobacco and substance use
Marital factors Number of married years, age at marriage, marital choice, consanguinity in marriage
Control over resources Household decision making, economic decision making, fertility, and contraceptive decision making
Fertility history and fertility intention Pregnancy history, menstruation, hygienic practices, delivery, post-natal care, unwanted pregnancy, post-
partum FP, male involvement in ANC, fertility desire preferences, STI/STD symptoms
Family planning Knowledge of FP, source of information, ever use, current use, barriers to use, FP discontinuation, intention
to use, contraceptive communication, abortion, knowledge, and resources about FP in community,
contraceptive self-efficacy, attitude towards home IUD insertion
Fertility attitudes Fertility desire, contraceptive preferences, fertility preference, contraceptive decision making, attitudes
towards FP use, attitude towards FP reproductive coercion, attitude towards husband involvement in FP,
provider FP coercion, interpersonal quality of FP services
Male gender norms (assessed only with
men)
Attitude towards gender roles
Gender-based abuse/control (assessed
only with women)
IPV-physical, verbal and sexual, injuries, help-seeking, attitude towards physical abuse, witnessing parental
IPV, reproductive coercion, mobility, public safety,
Sexual risk behaviors and STI symptoms Number of partners, commercial sex use, STI and UTI symptoms
Mental health Depression, generalized anxiety and suicidal ideation
Marital relationship quality Marital agreement, happiness and future success of relationship
Pregnancy Pregnancy test
NOTE: Details on scales and measures used for this survey can be made available upon request
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with 80% power given the 2-arm design with 20 clusters
of 48 measurable couples (assuming 80% retention) per
arm. Power calculations account for both within-village
and within-subcenter variance in clusters.
a) Based on the original CHARM study [14], we
expect the proportion of women using modern
contraception in the control group to be 40% at
18-month follow-up. This study will have 83.3%
power to detect an absolute difference of 12% or
more between treatment groups at follow-up, or
40% vs 52% in the two groups, with total kappa
[variance] = 0.10, assumed to be split equally
between within-village variance and within-cluster
variance.
b) Based on the original CHARM study [14], we expect
that 89.2% of women in the control group will report
no recent MSV at 18-month follow-up. We have
91.5% power to detect an absolute difference of 6% or
more between treatment groups (89.2% vs. 95.2%)
with kappa = 0.036, assumed to be split equally
between within-village variance and within-
cluster variance. The effect size of 6% difference
and the kappa = 0.036 were observed in the CHARM
study [14].
c) Based on the original CHARM study [14], we
expect the proportion of women reporting no
unintended pregnancy over 18-month follow-up to
be 90% in the control group. This study will have
89.5% power to detect an absolute difference of
5.5% or more between groups (90% vs. 95.5%), with
kappa = 0. The effect size of 5.5% difference is based
on a meta-analysis of cluster RCTs evaluating the
impact of FP interventions on unintended pregnancy
(with comparable measures to this study) [35]. The
study showed a 50% reduced risk for unintended
pregnancy amongst intervention participants, or
5.5%. The kappa = 0 is based on the CHARM study,
where no significant intra-cluster correlation was
found for this outcome.
While we will use longitudinal mixed-effects logistic
regression methods in our analyses, for power calcula-
tions we considered only comparison of the effects at
18-month follow-up. Power calculations for each hy-
pothesis used statistical simulations with 10,000 itera-
tions. We converted our kappas to the random cluster
effects using the delta method, and confirmed results
through the simulation.
Data analyses
Analyses will test whether CHARM2 participants rela-
tive to control participants are:
a) More likely to use contraception at 9 & 18-month
follow-ups;
b) Less likely to report MSV at 9 & 18-month follow-
ups;
c) Less likely to have an unintended pregnancy over
the 9 & 18-month follow-up periods.
The primary comparison of the binary outcomes be-
tween intervention groups at 9 & 18-months will use
mixed-effects longitudinal logistic regression, with ran-
dom effects for the individual (couple) and for geograph-
ical clusters (SCs), over time. The baseline will be
included as a time point (contraception and MSV out-
comes only). A categorical time effect will be used (pro-
file model). A difference-in-differences analysis will be
used to compare the treatment arms with control, test-
ing for an interaction between time and treatment arm
in the longitudinal model. In addition, the intervention
groups will be compared via a generalized estimating
equations (GEE) logistic regression analysis. The GEE
models will use a nested exchangeable working correl-
ation matrix that takes into account geographic clusters
and the individual (couple) within the cluster. No demo-
graphic covariates will be included in the primary ana-
lysis. Since the treatment assignment is at random, this
“unadjusted” analysis will provide a causal effect of the
intervention. However, we will also conduct secondary
analyses, adjusting for potentially relevant covariates
(e.g., age, current pregnancy, past year childbirth, etc.),
in addition to time and treatment arm, using backward
model selection at the α = 0.15 threshold level.
The primary analyses will use an intent-to-treat ap-
proach and analyze all subjects according to randomized
group. For subjects missing month 9 or 18 endpoints,
we will impute data from the lower (worse) half of the
distribution by arm (conservative approach) for sensitiv-
ity analyses. We will also conduct dose analyses, in
which we will include only those subjects who complete
the full intervention. Analyses will use women’s data
only for outcomes; however, we will use men’s data to
validate outcomes a) increased contraceptive use, and c)
reduced unintended pregnancy. We will conduct ex-
ploratory analyses using outcomes of contraception by
type if numbers are sufficient across time points.
Qualitative data on outcomes
We will also collect qualitative data from a subsample of
intervention participants (n = 50 couples, 5 couples from
each of the 10 intervention clusters), to understand the
significant behavior changes related to outcomes demon-
strated as significant in survey data. We describe further
detail on the content and procedures related to the col-
lection of these data below, in the implementation
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science section, as the purpose of these interviews is also
to describe implementation.
Cost-effectiveness
Should CHARM2 demonstrate effectiveness in accord-
ance with our hypotheses, we will conduct a cost-
effectiveness analysis using WHO-CHOICE method-
ology [36], an internationally accepted standard of eco-
nomic analysis of health programs. A senior level
economist will oversee this work. We are collecting
costs of the intervention prospectively, including capital
costs (e.g., equipment, space) and recurrent inputs (e.g.,
FP supplies, administrative costs). Given an expected
outcome of improved contraception, we will include in-
creases in non-CHARM2 FP services as partner costs.
We will discount costs at a rate of 3% per year, per
WHO-CHOICE recommendations, varying from 0 to
6% in the sensitivity analysis. We will assess drivers of
variation in the total program cost using multivariate
linear regression. We will calculate cost-effectiveness by
dividing the total program costs by total health out-
comes achieved over intervention duration. Our out-
come measures will include number reached by the
CHARM2 and unintended births averted (based on out-
come analyses). Based on prior research [37], we will use
an estimate of 3.8 DALYs averted per unintended birth
averted. We will also include quantitative measurements
of other benefits from unintended pregnancy prevention
(e.g., household savings and assets) to capture some of
the spillover effects of when unintended pregnancies are
prevented. Following WHO benchmarks, the interven-
tion will be categorized as ‘very cost-effective’ if the cost
per DALY averted is <1x the country’s per capita GDP
[38, 39]. We will undertake a probabilistic sensitivity
analysis, sampling each cost and outcome from an ap-
propriate distribution to determine mean incremental
cost-effectiveness, and assess drivers of uncertainty using
ANCOVA.
Implementation evaluation of CHARM2
In addition to a rigorous quantitative outcome evalu-
ation, this study also includes an implementation evalu-
ation, with a number of activities to help ensure fidelity
to design of the intervention and quality delivery, as well
as to track and monitor elements of implementation re-
quired for replication and scalability. This component
will involve quality assurance checks and monitoring
using the following efforts:
1) Standard training for all providers delivering or
supporting CHARM2 and training evaluation;
2) Periodic observation of CHARM2 providers by a
senior researcher with the team, and provision of
immediate feedback to providers;
3) Quarterly meetings among CHARM2 providers
with a senior researcher with the team, to discuss
difficult situations and determine ways to rectify
issues arising from program implementation;
4) In-depth interviews with CHARM2 providers and
select study participants to provide feedback on
their view of the intervention;
5) Brief participant satisfaction surveys with all
participants at the 9-month follow-up survey and
with providers quarterly, to assess their response
to program; these surveys will also allow us to
check for contamination between treatment groups.
We have outlined details on these efforts and their
purpose in Table 4. This includes information about the
data forms we will use for monitoring of implementa-
tion, as well as plans for management and use of these
data for quality control, to provide pragmatic feedback
for the program staff, and to document implementation
processes. Our implementation protocol is consistent
with best practices for process evaluation and implemen-
tation science recommended by the NIH Behavior
Change Consortium [40]. In addition to these efforts, we
also take pictures of trainings and intervention imple-
mentation in the field, with signed authorization on
photo release forms, to help document the project.
All above data collected from providers and partici-
pants are for purposes of implementation evaluation
only, and we will collect these data only after receipt
of informed written consent. We will use simple de-
scriptive analyses to analyze all quantitative data col-
lected for these purposes. Qualitative data will be
formally analyzed.
Qualitative data for implementation evaluation
We will collect in-depth interview data from a sub-
sample of CHARM2 participants and all CHARM2 pro-
viders to provide insight into the process of intervention
delivery, how it affects behavior and norm changes, and
how the program is perceived and valued. A subsample
of CHARM2 couples (n = 50, 5 couples per intervention
cluster) will be recruited to participate in in-depth inter-
views at 9-month follow-up to provide insight into their
perceptions of the CHARM2 intervention and its value,
as well as their experiences with FP and in their marital
relationship, generally and as a consequence of
CHARM2 participation. We will conduct interviews sep-
arately for women and men, with a gender-matched
interviewer. We will attempt to include couples who re-
ceived the full intervention and those who received only
part of the intervention. We will also conduct in-depth
interviews with CHARM2 providers (minimum n = 20)
to explore providers’ perspectives and experiences deliv-
ering CHARM2 and to assess their perceived impact on
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Table 4 Implementation Evaluation Forms and Activities for CHARM2
Form
* form is data entered
Who completes form
and when
Data management
and when
Purpose of form How are data reviewed
and used
Screening, Recruitment, & Monitoring Sessions
Recruitment and
tracking log
Who: Field staff
When: Each time a couple is
contacted. Additionally,
updated on a quarterly basis
for as long as participants stay
followed up.
Who: Field staff to collect
data and enter into tables.
They will review the data
weekly to ensure
recruitment numbers are
reaching their goal, and
recruitment rates are
acceptable. PC will compile
tables from field staff team
leaders into the master
excel file.
When: During recruitment,
weekly statistics on
recruitment numbers and
% of contacted couples
recruited summarized.
During follow-up, bi-
weekly reports of contact
attempts, contacts made
and the current follow-up
%.
To track recruitment rates,
refusal rates and reasons for
refusal. It will include
detailed tracking
information with contacts
of in-laws, natal family, a
neighbor on CommCare.
Will also track the comple-
tion of each survey. For any
loss to follow-up will track
any known reason for loss
to follow-up.
Reviewed by NIRRH/ PC
weekly. Discussed with
UCSD weekly, for
recruitment numbers, and
recruitment rates.
Training protocol
(for intervention)
N/A N/A Training protocol for
providers. Includes role play
and scoring on role play.
N/A
Training evaluation for
providers
Who: Providers
When: Before and after each
training, and booster training.
Who: Field staff to review
forms within 30 days of the
training. Could be paper-
based then manually
entered.
Filled pre- and post each
provider training. Evaluating
trainee’s knowledge before
and after training to assess
knowledge gained and any
need for specific content in
booster training. Roleplay
scores can also be used for
assessing need for booster
training. Booster training to
be conducted annually.
India team to assess topic
areas that training is not
effectively conveying and/
or areas that need booster
training. Booster and
additional trainings created
based on findings and
need.
Monitoring Intervention Quality and Delivery
Intervention curriculum
and delivery protocol
UCSD N/A Intervention curriculum for
3 sessions
N/A
Session Observation/
Checklist forms × 3 for
each session
Note: This will only take
place for 10% of
participants; there should
be different forms for each
intervention session
Who: 10% CHARM Intervention
Participants only (both male
and female participants)
When: At the end of each
randomly selected session
Who: Field staff will collect
and give to field manager
to review and process data
When: Once a month.
Casefile analyzed as
needed bases or at time of
observation.
Quality assurance to ensure
adherence to curriculum
and that providers are
providing the full program
to participants
Reviewed by NIRRH and PC
program manager,
monthly; Feedback
provided to Providers in
monthly meetings. Entered
with quantitative data;
analyzed biannually;
prevalence data used for
funder reports
Participant and Provider Feedback on Intervention
Participant Satisfaction
Survey
Who: Research team
administers satisfaction survey
to participants.
When: With the 9 months, or
18 months follow up survey if
not available at 9-month
follow-up
Who: Field staff will collect
data. The field manager
will input data. Program
manager will manage the
data
When: Frequencies to be
run by data analyst
monthly to review quality
and fidelity data.
Participant satisfaction with
CHARM2 intervention
Discussed quarterly with
UCSD. India team to discuss
in their meetings.
IDIs with couple
participants (husband
and wife separately)
Who: Research team
administers satisfaction survey
to 10% of participants who
received intervention and 10%
Who: Data are translated
and transcribed by the
field team in India.
When: Within 2 days of
To document participants’
perceptions of what they
received in the
intervention, what they
Discussed twice a year.
UCSD will compile data
and select quotes for
inclusion in reports.
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couples. In-depth interviews with the providers will ex-
plore their experience in delivering intervention sessions,
both individual and couples’ sessions, areas for improve-
ment, community acceptance, and perceived sustainabil-
ity of the program. While couple interviews will occur
one time, at 9-month follow-up, providers actively deliv-
ering the intervention will be asked to participate in
these interviews twice a year, or every 6 months to assess
ongoing intervention delivery. No incentives are offered.
Our trained research team will conduct all interviews
in a private location, with a gender-matched researcher.
We will record the interview unless the participant re-
fuses, in which case, the field researcher will take de-
tailed notes in English. Subsequent to the interview, and
within 48 h, the researcher will transcribe/translate these
interviews simultaneously for analysis. We will maintain
de-identified digital recordings and transcriptions, la-
belled with the participant’s unique identifier, to link
qualitative and quantitative data and to link provider
and participant data. We will import transcribed texts
into ATLAS.ti®, software that helps to organize and fa-
cilitate analysis of qualitative data [41]. We plan to
analyze these data using a grounded theory approach, in
which there is a continuous interplay between data col-
lection and analysis to iteratively generate themes and
adapt interview guides [42–44]. We will use the follow-
ing approach to our analysis:
1) Data Immersion- The field team and senior scientist
investigator on site will read and reread transcripts
and associated field notes to familiarize themselves
with the narratives and create memos to guide
theme development;
2) Theme Generation- The field team, again under the
guidance of the senior scientist in the field, will
develop a list of emergent key themes seen across
narratives;
3) Framework Development- Our scientific investigator
team will review and discuss the generated themes
and their intersections, to create a framework to
understand the issues of focus. We may develop
revisions to protocols or extensions of data collection
to better gain more insight;
4) Codebook Development- The senior scientist
investigator will develop a codebook based on the
framework themes, and a coding structure will be
created to guide further data analysis;
5) Coding and Iterative Analysis- The field team will
code and analyze all data using themes generated in
steps 2–4. We will have two coders review and
code each transcript using Atlas-ti. Coders will code
separately, and codes will be analyzed for inter-
coder reliability based on Cohen’s Kappa [45]. We
will review coding discrepancies to reach consensus.
New codes may emerge, and we may expand the
codebook and conduct another analysis of the data.
We may also recruit additional participants to reach
saturation in theme generation.
Based on findings from this approach, the framework
will be refined with the goal of helping clarify how the
intervention is able to support couples, and how the
providers effectively deliver the intervention.
Data safety and monitoring and protections for human
subjects
For all aspects of this study, we have developed our pro-
tocols to maintain ethical treatment of study participants
in accordance with our guidelines from our institutional
review boards. With regard to data safety monitoring of
study participants, we focus on two major safety aspects:
1) assurance that no harm comes to participants as a re-
sult of survey or program participation and 2) assurance
that all data collected from this project maintain the
Table 4 Implementation Evaluation Forms and Activities for CHARM2 (Continued)
Form
* form is data entered
Who completes form
and when
Data management
and when
Purpose of form How are data reviewed
and used
of participants who quit
When: 9 months follow up
interview completion. learned from the provider,
the quality of that learning
and how that learning
affected their relationship,
FP and MSV.
IDI with providers Who: Research team
administers satisfaction survey
to participants
When: Biannually, when no
survey data is being collected
Who: Field research team
When: Twice a year, 6
months apart.
To document providers
experiences with
intervention delivery, their
perceptions of how the
intervention affected
couples and how they
continue to see these
couples
Discussed twice a year.
UCSD will compile data
and select quotes for
inclusion in reports.
Note: The field manager and the scientist overseeing the field team will maintain notes from their ongoing meetings with field staff and from observations of
intervention delivery, to discuss key issues and generate plans for course correction or additional trainings as needed during the weekly to twice monthly
meetings with the full scientific investigator team
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privacy of research participants. Our senior scientists
based in India and included as co-authors on this paper
monitor the work in the field to ensure we adhere to our
monitoring protocols, with a designated site Principal
Investigator providing oversight.
To ensure that no harm comes to our participants, we
have instituted a number of protections. All participation
in this study requires written informed consent, ensuring
that all participants understand the nature of the study,
our efforts to maintain confidentiality, and their right to
withdraw from the study at any point. The informed
consent process also includes the name of an India-
based senior scientist overseeing ethical treatment of
participants, as noted above; we advise all participants
that they may contact this individual if they have any
concerns related to the study. We also make every effort
to minimize participants’ risk of a loss of confidentiality
during this study. The research team will not inform
participants’ family members or others of their participa-
tion, and we will not inform any spouse of the other’s as-
sessments as part of this study. We will de-identify all
data. We have also asked all research staff and providers
to maintain the confidentiality of all participants in the
study. As noted above in our description of data man-
agement, we will keep electronic files only in a password
protected project drive, and we will maintain paper
forms from the study in a locked file. All electronic files
will be backed up nightly to minimize the likelihood of
lost files or data.
Given the high rates of spousal violence seen in India
and globally, we have also included certain procedures
to reduce vulnerability for women experiencing spousal
violence, based on the WHO guidelines for domestic
violence research [46], and using an approach we have
used previously in India with no issues [14], as follows
(and noted in our procedures above):
 If women at any point in the study report life-
threatening violence from husbands or in-laws, these
women will be withdrawn from the study and
provided with supported referral (assistance with
transport and accompaniment) to the Mahila Hakka
Suraksha Samiti, a local domestic violence agency by
research staff. If non-life-threatening violence from
husbands or in-laws is reported, we will also share
information about local domestic violence services
with the participant.
 All research staff and intervention providers will be
trained on how to work with women affected by
domestic violence [46]. For example, this includes
using “dummy” questions if privacy is breached
during an interview or an ANM provider visit, and
training staff to identify when women are distressed
and need debriefing or immediate health attendance.
They will also offer support to conduct a safety plan
with a woman reporting spousal violence to ensure
she has thought through ways to safely escape her
situation should she choose to do so.
 Research and program staff will never disclose to
any family member who participated in the study,
what questions were asked of them, or what
responses were given. Participants will also be asked
not to share the questions and their responses with
others, particularly if they think it could put them at
risk for abuse.
 We will assess women for domestic violence, in
private places or environments where we can assure
confidentiality. As part of informed consent, we
clarify to all participants that they may refuse response
to a question, including questions on spousal violence.
 We train research staff to debrief with participants
as needed, validating that violence is never the
victim’s fault, there are services to support women
in this type of situation, and that the information
provided will not be shared with others in an
identifiable format.
Additionally, we have developed both internal and ex-
ternal data safety and monitoring procedures, and a plan
to determine if halting of study procedures are required
due to an identified harm to participants or others en-
gaged in the study. While we do not anticipate that
study involvement will cause harm, if this does occur, we
will adhere to the strict reporting requirements for ad-
verse events required by our institutional review board
approvals, inclusive of an annual reporting process.
The research team, in India and the U.S., will under-
take internal data safety and monitoring, as described
throughout this paper, and under the direction of the
Principal Investigator of the study, based at the Univer-
sity of California San Diego. As noted previously, we
hold scientific investigator meetings weekly to twice a
month to review and monitor data and field activities
and address any identified concerns. However, if the field
team identifies an adverse event, they will notify the
Principal Investigator by email within 72 h, and if it is a
serious adverse event, they will notify her within 24 h.
She, and all investigators overseeing IRB protocols re-
lated to this study, will inform their IRB within 48 h of
receiving notification of an adverse event or serious ad-
verse event. Meetings of the scientific investigations will
also be set within this period to consider how to address
the concern and reduce or eliminate the identified risk,
if related to the project and under our control.
We also have a Data Safety and Monitoring Board
(DSMB), developed for this study as an external moni-
toring body. Our DSMB consists of three independent
scientists with whom we meet via phone annually to
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review the study with them. We have asked this board
to review all procedures related to the protection of
study participants, including confidentiality procedures
and reports of distress. None of these scientists are
otherwise involved in this study, allowing objectivity re-
garding how best to handle an identified adverse event.
If we identify an adverse event, we will also review it
with our DSMB to obtain input on how to address the
concerns. We will only bring an issue to the attention of
the DSMB if one of the study investigators identifies a
need within 72 h of the standing meeting, at which point
that investigator will inform the team of his/her
intention to bring this forward. Otherwise, we will up-
date the DSMB twice a year on all identified adverse
events, to provide them with opportunity for input, un-
less no adverse events have occurred. If such updates are
required, we will draft a report reviewing all adverse
events or unexpected problems to date to share with our
DSMB and IRBs.
We do not anticipate any serious adverse events from
this study, but if we feel that the study is placing women
at increased risk for violence from their families or de-
velop any concerns, and we feel that we cannot rapidly
alter the study to reduce or eliminate this risk, we will
immediately halt the study.
Ethics approvals
All partner institutions on this study, the University of
California San Diego, the National Institute for Research
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Discussion
The CHARM2 Intervention is a five-session, gender-
synchronized intervention involving gender equity and
family planning counseling for married couples in rural
Maharashtra, India. The CHARM2 intervention builds
upon a previous iteration of the CHARM model which
focused on male-sessions, but not female sessions, to
support gender equity and family planning [13]. While
the original CHARM intervention demonstrated in-
creased modern contraceptive use, it showed no impact
on unintended pregnancy, likely due to reliance on lower
effectiveness forms of contraception such as male con-
doms [14]. CHARM did demonstrate reduced risk for
MSV, a concern for almost 1/3 of women in the study
sample [14] and a significant risk factor for condom non-
use and oral contraceptive failure [15, 16]. These findings
indicated that original CHARM sessions for men would
benefit from sessions for women, ideally delivered by a fe-
male ANM in the public health system and inclusive of a
broader array of contraceptive options. We designed
CHARM2 to utilize this gender-synchronized approach.
This protocol details planned evaluation of the
CHARM2 intervention to assess its impact on reversible
contraceptive use, MSV, and unintended pregnancy. The
evaluation includes both an outcome evaluation and an
implementation evaluation to assess quality of delivery
and document implementation for replicability and
scale-up. We will conduct our outcome evaluation via a
two-arm cluster RCT, which compares CHARM2
participants with the control arm, which receives SOC
FP services from the public health system. We are ad-
ministering surveys on family planning behaviors and
preferences to all participants, intervention and control,
and pregnancy tests to all female participants, at base-
line, 9 months follow-up and 18months follow-up. We
will evaluate the impact of CHARM2, relative to the
control condition, on reversible contraceptive use, preg-
nancy, and MSV over time.
We are also collecting qualitative data in the form of
in-depth interviews from both CHARM2 participants
and providers, to provide insight into how the interven-
tion affects these outcomes as well as perceptions of the
value of the intervention, the latter supporting the im-
plementation evaluation goals. Our implementation
evaluation involves a number of activities, including
these qualitative data efforts, to help ensure fidelity to
design of the intervention and quality delivery, as well as
to track and monitor elements of implementation re-
quired for replication and scalability. Included in these
activities are standardized training and monitoring of
CHARM2 providers and participant satisfaction surveys
from all participants, allowing for comparisons of expos-
ure and experiences with family planning counseling
across treatment groups. Should CHARM2 prove effect-
ive and sustainable, study findings will have broad impli-
cations for FP interventions for low resource settings in
India and elsewhere. Additionally, curricula, training
protocols, evaluation protocols, cost effectiveness find-
ings will have been developed to support its implemen-
tation and evaluation with other populations.
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